JUNE 14, 2018

Dr. Michael Bevilacqua, Amicrobe’s founder and CEO, was an invited speaker and panelist at an FDA supported meeting on the topic of developing “… Emerging Non-traditional Antibiotics”.

APRIL 24, 2018

Amicrobe, Inc., Developer Of Novel Technology For Antibiotic Resistance, Adds Safety Application To Intellectual Property Portfolio

APRIL 17, 2018

Antimicrobial Innovator Amicrobe, Inc. Positions Managment Team In Anticipation Of Product Trials

OCTOBER 24, 2017

Amicrobe, Inc. announces receipt of $2.48M award from award from CARB-X to accelerate development of Amicidin-β for treatment of life-threatening infections in surgery and trauma

3142 Tiger Run Court - Suite 101, Carlsbad, California 92010

+1 (888) 490-1180